Discover. Connect. Collect.®

Shop with Confidence
Secure Checkout
24/7 Support
Buyer Protection
CTCA Preferred Marketplace
A Preferred Marketplace of the Certified Trading Card Association (CTCA) Recognized for leadership, fair governance, and trusted trading.

Symbiote Spider-Man 2099 #1 Roge Antonio Design Variant

Skip to product information
1 of 1

Seller Credentials

Regular price $7.99 USD
Regular price Sale price $7.99 USD
Sold out

Enter your offer details

Seller Description

THERE WILL BE A NEW SYMBIOTE ON THE LOOSE! Comic legend PETER DAVID (THE INCREDIBLE HULK, SPIDER-MAN 2099) triumphantly returns to pen the next epic chapter in the Symbiote Saga alongside artist ROG ANT NIO (CARNAGE). THIS TIME, set your time circuits ahead to the techno-dystopian future of 2099! Miguel O'Hara, A.K.A. SPIDER-MAN 2099, is facing a hostile takeover - of his own body! Kron Stone, the VENOM of 2099, wages an all-out assault on Alchemax, and the only hope of stopping him lies with the power awakened by a top-secret project gone terribly wrong. What must Miguel sacrifice to seal the bond with his new symbiote - his body? His mind? His very soul?!

Seller Policy

Got similar items to sell? Join other enthusiasts to reach collectors around the globe.
Become a Seller

TradingCardsMarketplace.com AI Enhanced Listing Data

Product Type
Comic Book
Age Group
Adult
Autographed
No
Brand
Marvel
Card Number
1
Color
Multi-Colored
Condition
Used
Cover Artist
Roge Antonio
Cover Variant
Roge Antonio Design Variant
Error Card
No
Franchise
Marvel
Gender
Unisex
Issue Number
1
Language
English
Material
Paper
Memorabilia
No
Pattern
Standard
Player / Character
Spider-Man 2099
Publisher
Marvel
Rookie Card
No
Serial Numbered
No
Series Title
Symbiote Spider-Man 2099
Set Series
Symbiote Spider-Man 2099

AI-Powered Information

This data is AI-generated and unverified. Discrepancies in AI data do not qualify as "item not as described" under our Buyer Protection Policy. Only seller-provided title, images, and descriptions apply to buyer protection claims.